| Epithelioid hemangioendothelioma: update on diagnosis and treatment A Rosenberg, M Agulnik Current treatment options in oncology 19, 1-8, 2018 | 131 | 2018 |
| Optimizing treatment de‐escalation in head and neck cancer: current and future perspectives AJ Rosenberg, EE Vokes The oncologist 26 (1), 40-48, 2021 | 93 | 2021 |
| Immunotherapy in pancreatic adenocarcinoma—overcoming barriers to response A Rosenberg, D Mahalingam Journal of gastrointestinal oncology 9 (1), 143, 2018 | 48 | 2018 |
| Novel Strategies to Effectively De-escalate Curative-Intent Therapy for Patients With HPV-Associated Oropharyngeal Cancer: Current and Future Directions. KAR Price, AC Nichols, CJ Shen, A Rammal, P Lang, DA Palma, ... American Society of Clinical Oncology Educational book. American Society of …, 2020 | 33 | 2020 |
| A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer M Goldberg, A Manzi, A Birdi, B Laporte, P Conway, S Cantin, V Mishra, ... Nature communications 13 (1), 4829, 2022 | 32 | 2022 |
| Application of liquid biopsy as multi-functional biomarkers in head and neck cancer V Mishra, A Singh, X Chen, AJ Rosenberg, AT Pearson, A Zhavoronkov, ... British Journal of Cancer 126 (3), 361-370, 2022 | 27 | 2022 |
| AL101, a gamma-secretase inhibitor, has potent antitumor activity against adenoid cystic carcinoma with activated NOTCH signaling R Ferrarotto, V Mishra, E Herz, A Yaacov, O Solomon, R Rauch, ... Cell Death & Disease 13 (8), 678, 2022 | 26 | 2022 |
| Challenges and future of biomarker tests in the era of precision oncology: Can we rely on immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH) to select the … YK Chae, A Arya, L Chiec, H Shah, A Rosenberg, S Patel, K Raparia, ... Oncotarget 8 (59), 100863, 2017 | 24 | 2017 |
| Nivolumab, nabpaclitaxel, and carboplatin followed by risk/response adaptive de-escalated locoregional therapy for HPV-associated oropharyngeal cancer: OPTIMA II trial. A Rosenberg, N Agrawal, AT Pearson, TY Seiwert, Z Gooi, EA Blair, ... Journal of Clinical Oncology 39 (15_suppl), 6011-6011, 2021 | 23 | 2021 |
| Indoleamine 2, 3-dioxygenase 1 and overall survival of patients diagnosed with esophageal cancer AJ Rosenberg, DA Wainwright, A Rademaker, C Galvez, M Genet, L Zhai, ... Oncotarget 9 (34), 23482, 2018 | 22 | 2018 |
| Risk and response adapted de-intensified treatment for HPV-associated oropharyngeal cancer: Optima paradigm expanded experience AJ Rosenberg, N Agrawal, A Pearson, Z Gooi, E Blair, J Cursio, A Juloori, ... Oral oncology 122, 105566, 2021 | 20 | 2021 |
| Docetaxel, oxaliplatin, and 5‐fluorouracil (DOF) in metastatic and unresectable gastric/gastroesophageal junction adenocarcinoma: a phase II study with long‐term follow‐up AJ Rosenberg, A Rademaker, HS Hochster, T Ryan, T Hensing, ... The oncologist 24 (8), 1039-e642, 2019 | 18 | 2019 |
| Doublecortin-like kinase 1 (DCLK1) is a novel NOTCH pathway signaling regulator in head and neck squamous cell carcinoma EC Broner, JA Trujillo, M Korzinkin, T Subbannayya, N Agrawal, ... Frontiers in Oncology 11, 677051, 2021 | 17 | 2021 |
| Mutated HRAS activates YAP1–AXL signaling to drive metastasis of head and neck cancer S Jagadeeshan, M Prasad, M Badarni, T Ben-Lulu, VB Liju, ... Cancer research 83 (7), 1031-1047, 2023 | 10 | 2023 |
| A phase 1 dose-escalation study of RiMO-301 with palliative radiation in advanced tumors. M Koshy, M Spiotto, LE Feldman, JJ Luke, GF Fleming, D Olson, ... Journal of Clinical Oncology 41 (16_suppl), 2527-2527, 2023 | 9 | 2023 |
| Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response … AJ Rosenberg, E Izumchenko, A Pearson, Z Gooi, E Blair, T Karrison, ... BMC cancer 22, 1-8, 2022 | 9 | 2022 |
| A comprehensive AI‐driven analysis of large‐scale omic datasets reveals novel dual‐purpose targets for the treatment of cancer and aging FW Pun, GHD Leung, HW Leung, J Rice, T Schmauck‐Medina, S Lautrup, ... Aging Cell 22 (12), e14017, 2023 | 8 | 2023 |
| Enfortumab vedotin in the previously treated advanced head and neck cancer (HNC) cohort of EV-202. P Swiecicki, E Yilmaz, AJ Rosenberg, T Fujisawa, J Yang Bruce, C Meng, ... Journal of Clinical Oncology 41 (16_suppl), 6017-6017, 2023 | 7 | 2023 |
| A phase I trial evaluating NBTXR3 activated by radiotherapy in combination with nivolumab or pembrolizumab in patients with advanced cancers. C Shen, JM Frakes, J Niu, A Rosenberg, J Weiss, JJ Caudell, ... Journal of Clinical Oncology 39 (15_suppl), 2590-2590, 2021 | 7 | 2021 |
| First report of the safety/tolerability and preliminary antitumor activity of HB-201 and HB-202, an arenavirus-based cancer immunotherapy, in patients with HPV16+ cancers. AL Ho, MR Posner, J Niu, S Fu, RS Leidner, AT Pearson, KY Chung, ... Journal of Clinical Oncology 39 (15_suppl), 2502-2502, 2021 | 7 | 2021 |
